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Purpose: The purpose of the study was to assess the effect of cigarette smoking on indicators of
bone strength across a wide age range, controlling for physical activity and neuromuscular
performance.
Methods:Weconducteda cross-sectional studywith41 smokers (meanage SD, 41.016.1 yr) and
53 nonsmokers (47.5  18.2 yr) of both sexes. Bone strength indicators (BSI) were assessed in the
lower leg and forearm by peripheral quantitative computed tomography along with physical
activity, muscle cross-sectional area, and maximal voluntary muscle force.
Results: Physical activity level and muscle cross-sectional area of the leg and arm were similar in
smokers and nonsmokers. Although trabecular volumetric bone mineral density and epiphyseal
bone mineral content, both indicators of BSI, decreased with age in the nonsmokers’ tibia (P 
0.001), this was not observed in the smokers (interaction age smoking: P 0.014 and P 0.032
for density and content, respectively). Regression coefficients were nonsignificant in nonsmokers,
whereas coefficients in smokers were 1.24 mg/cm  yr [95% confidence interval (CI)  2.16–
0.33; P 0.01] for content and1.20 mg/cm3  yr (95% CI1.76–0.62; P 0.001) for trabecular
density. The BSI values in the smokers were independent of their smoking history (r2  0.000–
0.021), and no effects of sex were observed in the smoking-related differences in BSI.
Conclusions: Smoking compromises bone strength by diaphyseal marrow cavity expansion and
epiphyseal trabecular bone content reductions. These effects seem to wane with age. The causes
of the attenuated effect of smoking on bone at old age remain enigmatic but might be linked to
an interaction between the smoke-related factors and senescence processes affecting bone. (J Clin
Endocrinol Metab 95: 0000–0000, 2010)
Half a century ago,Doll andHill proposed (1) and thendemonstrated (2) that cigarette smoking elicits lung
cancer. Nowadays, a host of disorders is known that are
either caused or aggravated by smoking, such as coronary
heart disease, peripheral vascular disease (3), and chronic
obstructive pulmonary disease (COPD) (4).
A possible link between smoking and osteoporosis was
first proposed by Daniell in 1976 (5), and there is now
ample evidence to suggest that smoking does indeed in-
crease the risk of fractures (6–8). This elevated fracture
risk may be attributable to a reduction in bone strength,
becauseareal bonemineral density (aBMD), as assessedby
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dualx-rayabsorptiometry, is reduced in smokers at thehip
(9–11), the radius (12, 13), and the lumbar spine (10, 11).
It has to be considered, however, that dual x-ray ab-
sorptiometry does not allow for a detailed analysis of bone
geometry. It is therefore unclear from the above studies
whether smoking affects the material properties of bone
(e.g. degree of mineralization) and/or the morphology of
the bone (e.g. geometrical measures). Peripheral quanti-
tative computed tomography (pQCT) (14), which mea-
sures true volumetric bone mineral density (vBMD) and
thus allows the assessment of several bone strength indi-
cators (BSI), has recently been applied by Lorentzon et al.
(15) to address the question of how smoking affects bone.
They observed in young healthy male smokers a 4–5%
reduction in lumbar spine and femoral neck aBMD and in
distal tibia vBMD and cortical tibial area compared with
nonsmokers, confirming that smoking does affect bone at
the tissue level. Similar results have been obtained for the
radius of middle-aged (approximately 40 yr) men (16). It
is well known that the risk for osteoporotic fractures in-
creases with age. A metaanalysis by Law and Hackshaw
(17) suggests that “the effect of smoking on [areal] bone
mineral density increases cumulatively with age.” Yet,
Kanis et al. (8) found that the increased risk of hip fracture
related to smoking decreased with age. Hence, it is equiv-
ocal whether the effects of smoking on bone are aggra-
vated with age or not. Part of the discrepancies between
studies might be related to sex, as reflected by the reduced
radial cortical area in smokingwomenbutnot inmen (18),
or different levels of physical activity (19). Thus, a better
understanding of the interplay between aging and the ef-
fects of smoking upon bone is required. To this purpose,
we have organized a case-control study to compare the
effects of cigarette smoking upon forearm and lower leg
bone measures, as assessed by pQCT, in healthy smokers
and nonsmokers across the age range controlling for the
level of physical activity. We hypothesized that the effects
of smoking would be aggravated with increasing age and
that women would be affected to a greater extent com-
pared with men.
Participants and Methods
Participants
In total, 94 Caucasian adults volunteered for the study. Par-
ticipants were recruited from the local community. Nonsmokers
had never smoked in their lives. Participants were excluded if
they had been diagnosed with cardiovascular diseases (such as
stroke and chronic heart failure), arthritis, or used medications
known to affect bone metabolism (e.g. bisphosphonate therapy,
calcium supplementation, and hormone replacement therapy).
Ex-smokers, potentially pregnant women, and people suffering
from COPD were also excluded. To ensure the latter, all partic-
ipants underwent standard spirometry, and participants with a
predicted forced expiratory volume in 1 sec (FEV1pred) of less
than70%were excluded from further study. For pQCT, the right
lower leg and the right forearm were tested, unless they had been
fractured in the past, in which case the left limbwas tested (n 7).
All participants gave written informed consent, and proce-
dures were approved by the Local Ethics Committee andwere in
accordance with the Helsinki Declaration.
Assessment of smoking history
Smoking historywas assessed byquestionnaire. Smoking vol-
ume was given as cigarette pack-years, defined as the number of
cigarettepacks smokedperdaymultipliedby thenumberof years
smoked. Changes in smoking habits between the past and cur-
rent dose were taken into account.
Assessment of physical activity
Because exercise is nowadays believed to have important ben-
eficial effects on bone health (19), andmuscle contractions seem
to play an important role in skeletal integrity (20, 21), we have
matched smokers (n  41) and nonsmokers (n  53) for both
their physical activity level andmuscle force-generating capacity.
The level of physical activity was assessed by the Baecke ques-
tionnaire (22).Values less than7 represent a lowphysical activity
level.
Muscle strength
A subgroup of participants (n  62) also underwent mea-
surements of quadricepsmuscle functionby standarddynamom-
etry (Cybex norm dynamometer; Ronkonkoma, New York,
NY). The results of these experiments have been published else-
where (23). In short, quadriceps muscle cross-sectional area,
maximal voluntary force-generating capacity, and contractile
propertieswere similar in smokers andage- andphysical activity-
matched nonsmokers. In smokers, however, the skeletal muscle
resistance to fatiguewas significantly lower comparedwith non-
smokers, irrespective of the duration and intensity of smoking.
Scanning procedures
Scans by pQCT were obtained from the right forearm and
lower legwithanXCT2000 (StratecMedizintechnik, Pforzheim,
Germany) as described elsewhere (21, 24). Sectional imageswith
a pixel size of 0.5 mmwere obtained from the tibia at 4% (distal
epiphysis), 14% (metaphysis), and 38 and 66% (diaphysis) of its
length and from the radius at 4 and60%of the ulna’s length. The
scans taken at 66% of the tibia length and at 60% of the ulna
length were also used to assess gross anatomical muscle cross-
sectional area (Ar.Mus).
Image analysis and data processing
The image analysis and data processing are essentially similar
to previous studies (21). All scans were visually inspected before
further processing. Image analysis was performed according to
the manufacturer’s recommendations with the integrated XCT
software (version 6.00B). The XCT device produces pQCT im-
ageswhere the pixels are representative of vBMD. It is calibrated
to hydroxyl apatite, and the zero point is set to the apparent
vBMD of olive oil. All XCT analyses were performed with the
automated loop facility of the software package. Data were then
further processed with Microsoft Access.
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Using the XCT software, the outer bone contours were iden-
tified with the separation threshold set to 650 mg/cm3 for the
metaphysis and diaphysis and to 180 mg/cm3 for the epiphysis
(software option contour mode 1). A list of the pQCT variables
is given in Table 1. The following BSI were analyzed. Total volu-
metric bone mineral content (vBMC.tot) was taken as the
TOT_CNT value. For the diaphyseal sites, the polar moment of
resistance (RPol) was assessed as the RP_TOT_W value, and
cortical vBMD(vBMD.Ct) valueswere assessedwith adjustment
for the partial volume effect as previously described (25). Cor-
tical area (Ar.Ct) was taken as the variable CRT_A, and perios-
teal and endocortical circumferences (PsC andEsC, respectively)
were taken as the variables PERI_C and ENDO_C, respectively.
For the epiphyseal sites, trabecular vBMD (vBMD.tb) within the
central 45% of the epiphysis was also assessed, and the total
epiphyseal area (Ar.Epi) was assessed as an estimate of joint size.
All values of vBMC.tot were normalized for Ar.Epi unless oth-
erwise stated.
The Ar.Mus was assessed as follows. A region of interest was
set to cover the entire image. From this, the total limb cross-
sectional area (Ar.tot) and the combinedmuscle and bone cross-
sectional area (Ar.MB) was then assessed with an iterative con-
tour detection algorithm (software option contourmode 3) with
the threshold set to52mg/cm3 for Ar.tot and to 41mg/cm3 for
Ar.MB. In addition, a 5  5 smoothing filter was applied for
Ar.MB (software option F03F05). The combined bone area
(Ar.Bo; radius and ulna for the arm and tibia and fibula for the
leg) was segmented with a separation threshold of 650 mg/cm3,
and software option peel mode 2 with the inner threshold set to
100mg/cm3 to yield Ar.Bo. Ar.Muswas subsequently computed
as Ar.MB  Ar.Bo.
Statistical analyses
All variables were normally distributed. Group means were
compared using a univariate ANOVA with sex and smoking
classification as independent variables and age and Ar.Mus as
covariates. To evaluate the relationship between BSI and smok-
ing as a function of age, multiple linear regression analyses were
carried out with age, smoke  age, sex, sex  age, and Ar.Mus
(21) as independent predictors. To specifically investigate the
effects of aging on BSI, a similar multiple linear regression anal-
ysis was carried out but with only the nonsmokers included.
Physical activity as a covariate in the model did not improve the
regression model and was therefore excluded.
To investigate the effects of smokinghistory onBSI, cigarettes
smoked per week, years smoked, and cigarette pack-years were
fed into the model with only the smokers selected. Unstandard-
ized -values were used. Differences were considered significant
if P  0.05. All statistical testing was performed using SPSS
version 16.0 (SPSS Inc., Chicago, IL). Results are presented as
mean SD or mean (95% confidence interval) when accounting
for covariates.
Results
Participant characteristics
Table 2 shows the characteristics of the nonsmokers
(25 men and 28 women) and smokers (20 men and 21
women).Male and female smokershad smoked for21.3
20.1 and 27.0 13.0 yr, respectively, and were currently
consuming 17 12 and 15 6 cigarettes per day, respec-
tively. Smoking history was similar between men and
women. Age, weight, height, physical activity levels, and
FEV1pred were comparable in smokers and nonsmokers.
However, all smokers had a percent FEV1pred higher than
70%, suggesting that our cohort did not encompass pa-
tients with COPD.
Muscle scans by pQCT
For both the forearm and the lower leg, Ar.Mus did not
differ between smokers and nonsmokers (Table 2). How-
ever, Ar.Mus was smaller in women than men (P 0.001
for both sites). No difference was found inmuscle to bone
ratio between smokers and nonsmokers. There was no
sex-related difference in the muscle to bone ratio in the
lower leg, but the ratio was lower in the arm of women
than men (P  0.001).
Interactions between physical activity, muscle size,
and bone measures
The level of physical activity did not significantly im-
prove the prediction of BSI and was excluded from the
statistical analysis. However, participants with a higher
Ar.Mus (while controlling for physical activity level) also
had a higher vBMD.tb (r  0.514; P  0.001) and
vBMC.tot at the epiphysis (r  0.760; P  0.001) and
diaphysis (r  0.679; P  0.001). Similar results were
obtained for the radius.
Sex differences in bone measures in nonsmokers
Taking into account age- and sex-related differences in
Ar.Mus, we found in the nonsmokers group that men had
TABLE 1. List of pQCT variables and their acronyms
Acronym Variable
Ar.Bo Bone cross-sectional area
Ar.Ct Cortical cross-sectional area
Ar.Epi Epiphyseal cross-sectional area
Ar.Fat Subcutaneous fat cross-sectional area
Ar.MB Combined muscle and bone cross-sectional area
Ar.Mus Gross muscle cross-sectional area
Ar.tot Limb’s total cross-sectional area
EsC Endocortical circumference
M:B ratio Muscle to bone ratio
PsC Periosteal circumference
RPol Polar moment of resistance (adjusted for vBMD)
T.Fat Thickness of subcutaneous fat layer
vBMC Volumetric bone mineral content
vBMC.tot Total vBMC normalized for joint size
vBMD Volumetric bone mineral density
vBMD.Ct Cortical vBMD
vBMD.tb Trabecular vBMD
Acronyms are in accordance with the recommendations for
high-resolution pQCT by American Society for Bone and Mineral
Research (http://nomenclature.bb.asbmr.org).
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a similar vBMD.tb in their tibia epiphyses but greater
epiphyseal vBMC.tot (unnormalized) (P  0.001) than
women (Table 3). The greater joint size in men (Ar.Epi;
P 0.003) did largely account for this difference, because
vBMC.tot normalized for Ar.Epi was not different be-
tween the sexes (P0.073). Similar effectswere found for
the radius epiphysis (Table 3).
Group differences of bone measures are demon-
strated in Table 3. For the tibia diaphysis, men had a
significantly greater vBMC.Ct (P 0.001) and PsC (P
0.001, Table 3) than women. However, no sex differ-
ences were found for EsC and vBMD.Ct of the tibia and
the radius (Table 3). These differences were associated
with greater RPol in the tibia in men compared with
TABLE 2. Participant’s anthropometric characteristics (mean  SD)
Male nonsmokers
(n  25)
Female nonsmokers
(n  28)
Male smokers
(n  20)
Female smokers
(n  21)
Age (yr) 42.9  19.4 45.4  17.5 37.8  18.2 39.0  15.3
Height (m) 1.79  0.06 1.64  0.08b 1.77  0.06 1.64  0.05b
Weight (kg) 77  9 68  14b 76  11 70  12b
BMI (kg/m2) 23.9  1.9 24.8  4.8b 24.2  2.7 25.6  3.7b
Physical activity score 8.4  1.5 8.3  1.2 8.3  1.5 8.1  1.5
Cigarettes per day 0 0 17  12a 15  6a
Cigarette pack-years 0 0 16.7  20.5a 15.0  12.5a
FEV1pred (%) 99  13 102  15 90  11 97  15
Calf
Ar.Mus (cm2) 83.1  10.1 62.8  9.5b 78.4  10.1 61.9  6.5c
M:B ratio 10.0  2.0 9.5  1.6 9.6  1.5 10.3  2.8
Forearm
Ar.Mus (cm2) 44.1  6.5 27.8  3.2b 41.0  5.6 29.4  2.9c
M:B ratio 14.0  2.1 12.0  1.7b 13.1  1.8 12.7  1.5c
a Different from nonsmokers (P  0.05).
b Different from men (P  0.05).
c Different from men (P  0.001).
TABLE 3. BSI
Male
nonsmokers
(n  25)
Female
nonsmokers
(n  28)
Male
smokers
(n  20)
Female
smokers
(n  21)
Tibia 4% (epiphysis)
vBMC.tot (not normalized for Ar.Epi) (mg/mm) 472  58 323  50a 438  52b 316  60a
Ar.Mus (mm2) 13.3  1.4 11.1  0.9a 13.5  2.0 10.4  1.3a
vBMC.tot (mg/mm3) 35.6  4.3 29.1  3.7 32.9  5.0b 30.5  3.9
vBMD.tb (mg/cm3) 277  36 231  33 264  39 234  38
Tibia 38% (diaphysis)
vBMC.Ct (mg/mm) 462  49 335  56a 418  50b 333  36a
Ar.Ct (mm2) 375  41 271  44a 339  44b 267  30a
vBMD.Ct (mg/cm3) 1234  16 1228  32 1231  23 1245  33
RPol (mm3) 2390  421 1648  225a 2189  393 1574  323a
EsC (mm) 35.8  5.7 34.9  5.3 36.9  4.8 33.2  5.6
PsC (mm) 77.5  4.6 68.2  3.1a 75.0  4.5 66.8  4.6a
Radius 4% (epiphysis)
vBMC.tot (not normalized for Ar.Epi) (mg/mm) 172  24 114  20a 162  39 114  14a
Ar.Epi (mm2) 4.5  0.6 3.4  0.5a 4.6  1.1 3.5  0.5a
vBMC.tot (mg/mm3) 37.9  4.6 33.7  5.1 36.0  5.4 33.4  4.7
vBMD.tb (mg/cm3) 236  37 185  31 236  49 200  32
Radius 60% (diaphysis)
vBMC.tot (mg/mm) 135  17 97  14a 132  18 101  14a
Ar.Ct (mm2) 111  14 79  10a 109  14 82  12a
vBMD.Ct (mg/cm3) 1262  18 1267  31 1246  25 1271  14
RPol (mm3) 416  95 270  50 426  100 270  57
EsC (mm) 21.0  3.8 19.8  2.3 21.7  4.8 18.4  3.3
PsC (mm) 42.8  3.1 37.3  2.3a 43.0  3.3 37.1  2.3a
For explanation of acronyms see Table 1.
a P  0.05 compared with men.
b P  0.05 compared with nonsmokers, both accounting for age and muscle size.
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women (P  0.001). In the radius, unadjusted analyses
suggested sex-related differences in vBMC.Ct andRPol,
which were no longer significant after adjustment for
forearm Ar.Mus.
Effects of age in nonsmokers
In nonsmokers, vBMD.tb of the tibia was negatively
related to age (slope,1.12mg/cm3  yr; 95%CI1.60
to 0.63; P  0.001; Fig. 1A), and so was vBMC.tot
(0.14 mg/cm  yr; 95% CI  0.19 to 0.09; P 
0.001). Tibia EsC increased with age by 0.11 (95% CI
0.03 to 0.20) mm  yr (P  0.012; Fig. 1B), whereas
Ar.Ct tended to decline with age (P 0.068). Neither PsC
nor RPol were found to be correlated with age.
Similar results were obtained for the radius. vBMD.tb
was negatively related to age (slope, 0.78 mg/cm3  yr;
95% CI  1.38 to 0.17; P  0.013; Fig. 2A), and a
trend was found for vBMC.tot (slope, 0.08 mg/cm  yr;
95% CI  0.16–0.10; P  0.082). However, no age-
related differences in EsC or Ar.Ct were observed in the
diaphysis of the radius (Fig. 2B). Similarly, age did not
significantly affect PsCofboth the tibia and the radius, nor
did it affect RPol of both bones. Only after taking into
account physical activity as a covariate, the age  sex
interaction EsC of the radius was apparent as a significant
increase with age in the women only (P  0.045).
Effects of smoking on BSI
There were no significant main ef-
fects of smoking on the mean values of
BSI (Table 3). However, an interaction
effect of smoke  sex was discovered
for epiphyseal vBMC.tot (P  0.036)
and diaphyseal vBMC.tot (P 0.005),
implying lower values in smoking than
in nonsmoking men, whereas values
were similar between smoking andnon-
smoking women (Table 3). Similarly,
diaphyseal Ar.Ct in the tibia was lower
only in the smoking men compared
with their nonsmoking counterparts
(smoke  sex interaction, P  0.013).
EsC in the male smokers only tended to
be higher (smoke sex interaction,P
0.097), and PsC and RPol were similar
in smokers and nonsmokers of both
sexes. In the radius, Ar.Ct (P 0.093),
EsC, PsC, and RPol were all similar in
smokers and nonsmokers, and no
smoke sex interactions were observed.
Interestingly, however, although
vBMC.tot and vBMD.tb of the tibial
epiphysis decreasedwith age in the non-
smokers (both P  0.001), this effect
was not observed in the smokers (interaction age smok-
ing, P 0.004 and P 0.022 for v.BMC.tot and vBMD.
tb, respectively; Fig. 1A and Table 4). The slope was sig-
nificant in nonsmokers for vBMC.tot (0.14 mg/cm  yr;
95%CI0.19 to0.09; P 0.001) and for vBMD.tb
(1.12 mg/cm3  yr; 95% CI  1.60 to 0.63; P 
0.001) but not in the smokers [partial correlation,0.037
(P  0.835) and 0.111 (P  0.524) for vBMC.tot and
vBMD.tb, respectively], suggesting that young, but not
older, smokers have lower epiphyseal bone strength
compared with nonsmokers. Using these values for a
sample size estimation, it turned out that over 150
smokerswould have had to be tested to find a significant
aging effect in the smokers as observed in the nonsmok-
ers in this study.
Likewise for the tibia diaphysis, the observed increase
in EsC with age in the nonsmoking participants was not
present in smokers (interaction smoke age, P 0.038).
In the smokers, but not in the nonsmokers, the regression
coefficient for EsC over age was significant:0.14mm/yr
(95% CI  0.52–0.23; P  0.436; Fig. 1B), and the
intercept for smokers was 6.85 mm (95% CI  0.13–
13.58; P  0.046) greater than for nonsmokers. No dif-
ferences in age-related changes were observed in the PsC
between smokers and nonsmokers (Table 4). The differ-
FIG. 1. Trabecular density of the epiphysis (A and B) and endocortical circumference of the
diaphysis (C and D) of the tibia for smokers and nonsmokers of men (A and B) and women
(B and D). Although trabecular density declined (P  0.001; A and B) and endocortical
circumference increased (P  0.011; C and D) with age in the nonsmokers, no such
relationship was observed in the smokers. For slopes and 95% CI, see Results.
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ences in the slopes between smokers andnonsmokerswere
similar in both sexes.
Smoking effects upon vBMC.tot and vBMD.tb (Fig.
2A) in the radius were similar to the tibia, albeit less pro-
nounced. In the nonsmokers, the vBMC.tot demonstrated
a trend to decrease with age by 0.08 mg/cm  yr (95%
CI0.16–0.10; P 0.082), whereas it did not change
in the smokers (interaction, P 0.034 and P 0.459 for
slope in smokers only). Similar values were obtained for
vBMD.tb, for which the slope was 0.78 mg/cm3  yr
(95% CI  1.38 to 0.17) in nonsmokers and 1.33
mg/cm3  yr (95% CI1.38–4.04) in the smokers (in-
teraction, P  0.004; Fig. 2A). No age or age smoking
effectswere observed in EsC (Fig. 2B) or PsC of the radius.
Similarly to the tibia, the differences in the slopes between
smokers andnonsmokers in the radiuswere similar inboth
sexes.
Relation between smoking exposure and BSI
When years smoked, cigarette smoked per week, and
cigarette pack-years were fed into the multiple linear re-
gression model with only the smokers selected, no rela-
tionships were observed between smoking exposure and
BSI (P values ranged from 0.110–0.999).
Discussion
This study has shown that in young
smokersofeithersex, theepiphysealbone
mineral content and trabecular vBMD
are reduced, whereas there is no reduc-
tion in cortical vBMD. In addition, in
male, but not female, smokers, tibial di-
aphyseal cortical area is reduced com-
paredwithnonsmokers.Thisstudythere-
fore supports the view that reduced
aBMD in smokers (9, 10, 12, 13) is
caused by reductions in bone mass (15,
16, 18) as well as by marrow cavity ex-
pansion. In addition, we observed that
the bones of men appear to be more af-
fected by smoking than those of women.
The principle hypothesis of the present
study was that the effects of smoking on
BSI, such as trabecular density and bone
mineral content, would be aggravated
with increasing age. Quite clearly, this
does not seem to be the case, and the op-
posite appears tobe true, because thedet-
rimentaleffectsofcigarette smokingwere
most pronounced at a young age and
were mitigated at an older age. These re-
sults are not explicable by differences in
physical activity level or parameters of neuromuscular func-
tioning between groups because these parameterswere care-
fully controlled in the present study.
Our data are in good agreement with a number of stud-
ies that have reported detrimental effects of smoking on
bone (9–13, 15, 16, 18, 26). This effect appeared to be
independent of the current or cumulative dose of smoking
in bothmen andwomen and extends similar observations
by Lorentzon et al. (15) in young men.
Interestingly, the effectsof smokingappearedmore severe
inmen than in women. Although inmen the cortical area of
the diaphysis and the vBMC.tot were reduced in the tibia as
a result of smoking, no such effect was observed in women.
Our data are in some contrast to those of Kaji et al. (18).We
have no explanation for this discrepancy, but it is possible
that part of it is related to differences in the study pop-
ulation (Asians vs. Caucasians), and probably also to
the fact that groups in our study were matched for phys-
ical activity and that there was no difference in muscle
function between smokers and nonsmokers (23).
It was concluded from a metaanalysis (17) that the frac-
ture risk attributable to smoking is aggravated with increas-
ing age and that this aggravation is mediated by a reduction
in aBMD. In these studies, however, the data were obtained
FIG. 2. Trabecular density of the epiphysis (A and B) and endocortical circumference of
the diaphysis (C and D) of the radius for smokers and nonsmokers of men (A and C) and
women (B and D). Although trabecular density declined (P  0.013; A and B) in the
nonsmokers, no such relationships were observed in the smokers. Endocortical circumference
(C and D) did not change with age in smokers or nonsmokers. For slopes and 95% CI,
see Results.
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with a variety of methods and from different skeletal sites,
and the inclusionandexclusion criteria variedwidely among
studies. In amore stringentmetaanalysis of 10 prospectively
studied large cohorts, it was shown that the fracture risk
attributable to smoking was mitigated, rather than in-
creased,with age (8).Our data confirm this observation and
provide evidence that this mitigation of the detrimental ef-
fects of smoking on BSI is not an effect mediated by changes
in physical activity and/or neuromuscular performance.
Mechanisms by which cigarette smoking affects
bone strength
Nicotine has been reported to compromise bone mass
and strength (27). Also, other toxic factors in cigarette
smoke, such as carbon monoxide, (hydrogen) cyanide,
formaldehyde, and benzene may have detrimental effects
upon bone (28). It is, however, difficult to see how such
toxic effects could become bluntedwith age. One possible
explanation for such blunting might be mediated via the
endocrine system. Kiel et al. (29), for instance, have re-
ported that smoking compromises aBMD in postmeno-
pausal women who took estrogen replacement therapy
but not in those that did not, whichwas interpreted by the
authors as a hint that smoking may affect bone metabo-
lism via its action upon estrogen. However, a number of
studies demonstrated detrimental effects of smoking on
bone in the absenceof differences inplasma estrogen levels
(15, 30).Moreover, the age-relatedmitigation of smoking
TABLE 4. Results for the linear regression modeling of BSI with the following factors entered into the model:
smoking, age, smoke  age, sex, age  sex, and muscle size
Slope () 95% CI P value,   0
Tibia
vBMD.tb tibia (epiphysis)
Age (nonsmokers only) 1.12 1.60 to 0.63 0.001
Smoke 51.5 93.60 to 9.50 0.014
Smoke  age 1.04 0.15, 1.93 0.022
vBMC.tot tibia 4% (epiphysis)
Age (nonsmokers only) 0.14 0.19 to 0.09 0.001
Smoke 7.45 12.34 to 2.57 0.030
Smoke  age 0.15 0.05–0.26 0.004
Ar.Ct tibia 38% (diaphysis)
Age (nonsmokers only) 0.63 1.31–0.05 0.068
Smoke 29.35 78.18–19.48 0.235
Smoke  age 0.19 0.84–1.22 0.709
EsC tibia 38% (diaphysis)
Age (nonsmokers only) 0.11 0.03–0.20 0.012
Smoke 6.85 0.13–13.58 0.046
Smoke  age 0.15 0.29 to 0.01 0.038
EsC tibia 38% (diaphysis)
Age (nonsmokers only) 0.00 0.06–0.07 0.902
Smoke 0.86 4.45–6.16 0.749
Smoke  age 0.06 0.17–0.05 0.311
Radius
vBMD.tb radius 4% (epiphysis)
Age (nonsmokers only) 0.78 1.38 to 0.17 0.013
Smoke 52.07 98.93 to 5.21 0.030
Smoke  age 1.36 0.36–2.35 0.009
vBMC.tot radius 4% (epiphysis)
Age (nonsmokers only) 0.08 0.16–0.10 0.082
Smoke 7.67 13.90 to 1.43 0.017
Smoke  age 0.14 0.01–0.28 0.034
Ar.Ct radius 60% (diaphysis)
Age (nonsmokers only) 0.04 0.25–0.16 0.672
Smoke 7.04 20.78–6.70 0.310
Smoke  age 0.19 0.10–0.49 0.190
EsC radius 60% (diaphysis)
Age (nonsmokers only) 0.04 0.02–0.11 0.187
Smoke 2.09 2.88–7.05 0.405
Smoke  age 0.05 0.15–0.06 0.308
PsC radius 60% (diaphysis)
Age (nonsmokers only) 0.01 0.04–0.06 0.584
Smoke 0.05 3.36–3.25 0.974
Smoke  age 0.01 0.06, 0.08 0.826
For explanation of acronyms see Table 1.
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effects in our study occurred in men but not in women
alike. It would therefore appear that a decline in bone
strength is probably not mediated via estrogen alone.
Other hormones that play a role in bone metabolism and
can be affected by smoking are cortisol (31), vitamin D
(32), and PTH (32). Finally, it is possible that smoking
interferes more or less directly with processes involved in
senescence. Oxidative stress, for example, is thought to
increase with age in most if not all parts of our body. Like-
wise, oxidative stress increases even after smoking a single
cigarette (23,33)andmaystimulateosteocyteapoptosis (34)
and remodeling (35) and underlie the enhanced bone turn-
over often reported in heavy smokers (36).
Limitations
This is a case-control study, and it can therefore not
prove causality. In other words, the differences between
the smokers’ and the nonsmokers’ bones outlined here
could have been caused by a third factor that affects the
decision to either smoke or not. For example, there is a
likely bias to exclude the more unhealthy of the elderly
smokers, due to the strict criteria for inclusion into this
study. In theory, such an effect could have caused the mit-
igationof thenegative effects on smokinguponboneat old
age. However, the mechanisms required for this would
have to be rather indirect.Moreover, and from a practical
point of view, controlled interventional studies, where
people are asked to initiate smoking are ethically inap-
propriate, given the known toxic effects of cigarette smok-
ing. Cohort studies are quite resource intensive and as
much prone to self-selection bias as the current case-con-
trol study. We therefore believe that the evidence pre-
sented here is as strong as practically possible.
The sample size might be considered small, and there-
fore we did some sample size calculations. Using the
changes in vBMD.tb, we would have needed at least 150
smokers to obtain a power of 0.8. It should be noted that
in the nonsmokers, 53 people were enough to show an
age-related decline in this parameter, emphasizing that the
effect of age is stronger in nonsmokers than smokers, if it
exists in the latter group at all.
Finally, it would have been desirable to also study tra-
becularbone structure in this cohort, inparticular toassess
differential effects of smoking and age upon the cortical
and trabecular compartments in the epiphysis (37, 38).
This would have required a scanner with greater resolu-
tion, which was not available to us at the time that this
study was conducted. Nevertheless, resolution issues are
unlikely to have affected the results presented here.
Conclusions
In conclusion, the present data suggest that smoking
compromises bone strength by diaphyseal marrow cavity
expansion and epiphyseal trabecular bone reductions.
These effects were more pronounced in men than in
women and appear to wane with age. The cause of this
remains enigmatic, but it is possible that the effects of
smoking on bone interfere with the senescence processes.
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